YNIOS Pharma 3A

Equity
€68,500
total amount raised in round
  • Backed by over 50 investors
  • Eligible for a tax reduction
This campaign has been closed
This campaign has ended. If you have any more questions or remarks, do not hesitate to contact us via info@spreds.com.

Kevin G

Hi - Can you disclose the valuation of the Spreds 1A first round?

Thank you.

Kevin G

Next to the spreds compartiment and grants, how much was raised via other channels in the past 2 years?

Jean P

Dear Sir,
The company raised 500.000 EUR from private insvestors outsie of SPREDS.
Let me correct my previous answer, the amount raised by SPREDS in the first round was 105.000 EUR and not 205.000 EUR. The company also received another 10.300 EUR from SPREDS' investors in preferential rights adjustments.
Kind regards
JF Plucker

Jean P

Dear Kevin, YNIOS Pharma just held its board meeting and its shareholders' annual meeting. You may be interested to know that both assemblies have decided to entrust an expert to proceed with the valuation of the company. As a reminder, the company's current valuation reflects its number of shares of 1 EUR each, i.e. just above 6M€. The new valuation will take into account the market value of the R&D programs and of the patents and patents pending of the company.. This new evaluation will create a premium for each share which may multiply the value of the share by a factor, possibly between 2 to 10. This will have been the first value jump of the company. The company will post its new value and share premium when the process is completed. So hang-on and wait a few more weeks. It will be worth it !
Kind regards
JF Plucker

Kevin G

Thank you very much for your swift reply.

Jean P

Dear Sir,
205.000 EUR were raised by Spreds in the first round.
I hope this answers your question.
Best regards
JF Plucker